Gyre Therapeutics, Inc. (GYRE)
NASDAQ: GYRE · Real-Time Price · USD
7.12
-0.37 (-4.94%)
Sep 23, 2026, 10:47 AM EDT - Market open
Gyre Therapeutics Market Cap
Gyre Therapeutics has a market cap or net worth of $754.96 million as of September 23, 2026. Its market cap has increased by 11.27% in one year.
Market Cap
754.96M
Enterprise Value
683.58M
1-Year Change
11.27%
Ranking
Category
Stock Price
$7.12
ChartMarket Cap Chart
Since October 31, 2023, Gyre Therapeutics's market cap has increased from $515.41M to $754.96M, an increase of 46.48%. That is a compound annual growth rate of 14.07%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 23, 2026 | 754.96M | 17.65% |
| Dec 31, 2025 | 641.69M | -38.21% |
| Dec 31, 2024 | 1.04B | -47.22% |
| Dec 29, 2023 | 1.97B | 281.72% |
| Oct 31, 2023 | 515.41M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| 4D Molecular Therapeutics | 841.92M |
| Wave Life Sciences | 838.44M |
| Geron | 835.22M |
| Achieve Life Sciences | 828.37M |
| BlossomHill Therapeutics | 821.25M |
| Aclaris Therapeutics | 819.90M |
| Annexon | 800.02M |
| Design Therapeutics | 785.40M |